×
About 1,908 results

ALLMedicine™ Uterine Cancer Center

Research & Reviews  503 results

Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer
https://clinicaltrials.gov/ct2/show/NCT03325634

May 13th, 2022 - This is a phase I study with a primary objective to determine maximum tolerated dose (MTD) of 3 fraction stereotactic body radiation therapy (SBRT) for abdominopelvic recurrences of ovarian cancer (OC) and uterine papillary serous carcinoma (UPSC)...

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
https://clinicaltrials.gov/ct2/show/NCT04579380

May 10th, 2022 - There are multiple cohorts in this trial: 5 tumor specific cohorts with HER2 overexpression/amplification (cervical cancer, uterine cancer, biliary tract cancer, urothelial cancer, and non-squamous non-small cell lung cancer [NSCLC]) 2 tumor speci...

Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality...
https://doi.org/10.1001/jamaoncol.2022.0009
JAMA Oncology; Clarke MA, Devesa SS et. al.

May 6th, 2022 - Uterine cancer incidence has been increasing, particularly rates of aggressive, nonendometrioid subtypes, which are disproportionately higher among non-Hispanic Black women. The association of subtype-specific trends with uterine cancer mortality ...

Single centre experience of 800 gynaecologic oncology cases in 2020: influence of pande...
https://doi.org/10.1080/01443615.2022.2049716
Journal of Obstetrics and Gynaecology : the Journal of Th... Ozturk UK, Akis S et. al.

Apr 28th, 2022 - We aimed to evaluate the gynaecological oncology surgeries in the COVID-19 pandemic. A total of 800 operations performed between January and December 2020 were retrieved. Since the COVID-19 pandemic affected operations as of April 1 2020, we compa...

Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Tr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011178
JAMA Oncology; Leung E, Gladwish AP et. al.

Apr 15th, 2022 - Adjuvant radiation plays an important role in reducing locoregional recurrence in patients with uterine cancer. Although hypofractionated radiotherapy may benefit health care systems and the global community while decreasing treatment burden for p...

see more →

Guidelines  4 results

Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Ear...
https://doi.org/10.1097/AOG.0000000000002289
Obstetrics and Gynecology;

Aug 24th, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r...

Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detec...
https://doi.org/10.1097/AOG.0000000000002299
Obstetrics and Gynecology;

Aug 24th, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r...

BGCS uterine cancer guidelines: Recommendations for practice.
https://doi.org/10.1016/j.ejogrb.2017.04.015
European Journal of Obstetrics, Gynecology, and Reproduct... Sundar S, Balega J et. al.

Apr 25th, 2017 - The British Gynaecological Cancer Society has issued the first Endometrial (Uterine) Cancer guidelines as recommendation for practice for the UK.

Uterine neoplasms, version 1.2014.
https://doi.org/10.6004/jnccn.2014.0025
Journal of the National Comprehensive Cancer Network : JN... Koh WJ, Greer BE et. al.

Mar 4th, 2014 - Adenocarcinoma of the endometrium (also known as endometrial cancer or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. An estimated 49,560 new uteri...

see more →

Drugs  48 results see all →

Clinicaltrials.gov  26 results

Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer
https://clinicaltrials.gov/ct2/show/NCT03325634

May 13th, 2022 - This is a phase I study with a primary objective to determine maximum tolerated dose (MTD) of 3 fraction stereotactic body radiation therapy (SBRT) for abdominopelvic recurrences of ovarian cancer (OC) and uterine papillary serous carcinoma (UPSC)...

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
https://clinicaltrials.gov/ct2/show/NCT04579380

May 10th, 2022 - There are multiple cohorts in this trial: 5 tumor specific cohorts with HER2 overexpression/amplification (cervical cancer, uterine cancer, biliary tract cancer, urothelial cancer, and non-squamous non-small cell lung cancer [NSCLC]) 2 tumor speci...

A Study of Nivolumab in Selected Uterine Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT03241745

Apr 5th, 2022 - The purpose of this study is to test the safety of nivolumab and find out what affects, if any, nivolumab has on people and their risk of gynecologic cancer. The investigators also want to find out what effects, good or bad, nivolumab has on the p...

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
https://clinicaltrials.gov/ct2/show/NCT04080284

Mar 18th, 2022 - Uterine serous carcinoma (USC) accounts for up to 40% of endometrial cancer-related deaths. In contrast to the more common endometrioid histology, USC is more likely to present in advanced stage and carries a worse prognosis. USC mimics the most c...

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples
https://clinicaltrials.gov/ct2/show/NCT02239575

Mar 16th, 2022 - CANCER INDICATIONS: Bladder Cancer - Urothelial carcinoma - nonpapillary Bladder Cancer - Urothelial carcinoma - papillary Brain Cancer - Astrocytoma Brain Cancer - Glioblastoma Brain Cancer - Medulloblastoma Breast Cancer - Ductal Carcinoma Breas...

see more →

News  177 results

FDA Rejects More China Drugs; Clue to Uterine Ca Disparity; Cancer-Vax Controversy
https://www.medpagetoday.com/hematologyoncology/othercancers/98587

May 6th, 2022 - China-based Hutchmed announced receipt of a complete response letter from the FDA, stating that the agency cannot approve the tyrosine kinase inhibitor surufatinib for advanced neuroendocrine tumors without support from a multiregional clinical tr...

Matulonis’ Passion Drives Gynecologic Cancer Research Into the Next Era
https://www.onclive.com/view/matulonis-passion-drives-gynecologic-cancer-research-into-the-next-era

Apr 7th, 2022 - Specialization in oncology research affords investigators the opportunity to dive into tumor biology and uncover unique approaches to care. But specialization does not mean siloed approaches. Cross-functional team collaboration coupled with insigh...

Changing Landscape of Uterine and Ovarian Cancer in the US
https://www.medscape.com/viewarticle/968303

Feb 11th, 2022 - NEW YORK (Reuters Health) - The landscape of gynecologic cancer in the United States is changing rapidly and the risk of dying from uterine cancer is now similar to that for ovarian cancer among women overall, and roughly 60% higher among Black wo...

Paclitaxel-Carboplatin Established as Standard of Care for Uterine Carcinosarcoma
https://www.medpagetoday.com/hematologyoncology/othercancers/96856

Jan 25th, 2022 - Median overall survival (OS) and progression-free survival (PFS) in uterine carcinosarcoma (UCS) both improved with paclitaxel and carboplatin as compared with a standard-of-care regimen, a randomized trial showed. OS improved from 29 months with ...

Long-Excluded Uterine Cancer Patients Are Step Closer to 9/11 Benefits
https://www.medscape.com/viewarticle/966566

Jan 13th, 2022 - Tammy Kaminski can still recall the taste of benzene, a carcinogenic byproduct of burning jet fuel. For nine months after the 9/11 attacks, she volunteered for eight hours every Saturday at St. Paul's Chapel, just around the corner from ground zer...

see more →

Patient Education  5 results see all →